{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:05:10Z","timestamp":1704953110082},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurological manifestations of coronavirus disease 2019 (COVID-19) have been frequently described. In this prospective study of hospitalized COVID-19 patients without a history of neurological conditions, we aimed to analyze their prevalence and prognostic value based on established, standardized and objective methods. Patients were investigated using a multimodal electrophysiological approach, accompanied by neuropsychological and neurological examinations. Prevalence rates of central (CNS) and peripheral (PNS) nervous system affections were calculated and the relationship between neurological affections and mortality was analyzed using Firth logistic regression models. 184 patients without a history of neurological diseases could be enrolled. High rates of PNS affections were observed (66% of 138 patients receiving electrophysiological PNS examination). CNS affections were less common but still highly prevalent (33% of 139 examined patients). 63% of patients who underwent neuropsychological testing (<jats:italic>n<\/jats:italic>\u2009=\u2009155) presented cognitive impairment. Logistic regression models revealed pathology in somatosensory evoked potentials as an independent risk factor of mortality (Odds Ratio: 6.10 [1.01\u201365.13], <jats:italic>p<\/jats:italic>\u2009=\u20090.049). We conclude that hospitalized patients with moderate to severe COVID-19 display high rates of PNS and CNS affection, which can be objectively assessed by electrophysiological examination. Electrophysiological assessment may have a prognostic value and could thus be helpful to identify patients at risk for deterioration.<\/jats:p>","DOI":"10.1038\/s41598-023-46124-w","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:02:37Z","timestamp":1699624957000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessments"],"prefix":"10.1038","volume":"13","author":[{"given":"Carolin","family":"Balloff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Bandlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Brandenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Bludau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Elben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Feldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Heinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Ingwersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn-Erik O.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Kindgen-Milles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris-Katharina","family":"Penner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Slink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Stramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kathrin","family":"Telke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Vetterkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan J.","family":"Groiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"46124_CR1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012930","author":"S Misra","year":"2021","unstructured":"Misra, S. et al. Frequency of neurologic manifestations in COVID-19: A systematic review and meta-analysis. Neurology https:\/\/doi.org\/10.1212\/WNL.0000000000012930 (2021).","journal-title":"Neurology"},{"issue":"6","key":"46124_CR2","doi-asserted-by":"publisher","first-page":"e0263595","DOI":"10.1371\/journal.pone.0263595","volume":"17","author":"B Singh","year":"2022","unstructured":"Singh, B. et al. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis. PLoS One 17(6), e0263595. https:\/\/doi.org\/10.1371\/journal.pone.0263595 (2022).","journal-title":"PLoS One"},{"issue":"7","key":"46124_CR3","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00415-023-11768-1","volume":"270","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak, A. et al. Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: An individual participant data meta-analysis. J. Neurol. 270(7), 3315\u20133328. https:\/\/doi.org\/10.1007\/s00415-023-11768-1 (2023).","journal-title":"J. Neurol."},{"key":"46124_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51496","author":"J Bungenberg","year":"2022","unstructured":"Bungenberg, J. et al. Long COVID-19: Objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. https:\/\/doi.org\/10.1002\/acn3.51496 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"46124_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000686","volume":"4","author":"AM Cervantes-Arslanian","year":"2022","unstructured":"Cervantes-Arslanian, A. M. et al. Neurologic manifestations of severe acute respiratory syndrome Coronavirus 2 infection in hospitalized patients during the first year of the COVID-19 pandemic. Crit. Care Explor. 4(4), e0686. https:\/\/doi.org\/10.1097\/CCE.0000000000000686 (2022).","journal-title":"Crit. Care Explor."},{"key":"46124_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756286421993701","volume":"14","author":"M Fleischer","year":"2021","unstructured":"Fleischer, M. et al. Observational cohort study of neurological involvement among patients with SARSCoV-2 infection. Ther. Adv. Neurol. Disord. 14, 1\u201314 (2021).","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"46124_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/NRL.0000000000000379","volume":"26","author":"C Haki","year":"2021","unstructured":"Haki, C., Demirci, H., Ayar, Y., Demir, C. & Caliskan, G. Neurological symptoms and diagnoses in patients hospitalized With COVID-19: Relationships with mortality. Neurologist 26(6), 237\u2013243. https:\/\/doi.org\/10.1097\/NRL.0000000000000379 (2021).","journal-title":"Neurologist"},{"issue":"12","key":"46124_CR8","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1111\/ene.15072","volume":"28","author":"NN Kleineberg","year":"2021","unstructured":"Kleineberg, N. N. et al. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS). Eur. J. Neurol. 28(12), 3925\u20133937. https:\/\/doi.org\/10.1111\/ene.15072 (2021).","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"46124_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77(6), 683\u2013690. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127 (2020).","journal-title":"JAMA Neurol."},{"issue":"9","key":"46124_CR10","doi-asserted-by":"publisher","first-page":"e18131","DOI":"10.7759\/cureus.18131","volume":"13","author":"J Kumar","year":"2021","unstructured":"Kumar, J. et al. Long-term neurological impact of COVID-19. Cureus. 13(9), e18131. https:\/\/doi.org\/10.7759\/cureus.18131 (2021).","journal-title":"Cureus."},{"key":"46124_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00542-2020","author":"YMJ Go\u00ebrtz","year":"2020","unstructured":"Go\u00ebrtz, Y. M. J. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome?. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00542-2020 (2020).","journal-title":"ERJ Open Res."},{"key":"46124_CR12","doi-asserted-by":"publisher","first-page":"574004","DOI":"10.3389\/fneur.2020.574004","volume":"11","author":"SJ Groiss","year":"2020","unstructured":"Groiss, S. J. et al. Prolonged neuropsychological deficits, central nervous system involvement, and brain stem affection after COVID-19-A case series. Front. Neurol. 11, 574004. https:\/\/doi.org\/10.3389\/fneur.2020.574004 (2020).","journal-title":"Front. Neurol."},{"issue":"4","key":"46124_CR13","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s10072-021-05816-9","volume":"43","author":"A Koskderelioglu","year":"2022","unstructured":"Koskderelioglu, A., Eskut, N., Ortan, P., Ozdemir, H. O. & Tosun, S. Visual evoked potential and nerve conduction study findings in patients recovered from COVID-19. Neurol. Sci. 43(4), 2285\u20132293. https:\/\/doi.org\/10.1007\/s10072-021-05816-9 (2022).","journal-title":"Neurol. Sci."},{"issue":"11","key":"46124_CR14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33(11), 1444\u20131452. https:\/\/doi.org\/10.1212\/wnl.33.11.1444 (1983).","journal-title":"Neurology"},{"issue":"5","key":"46124_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. & van Gijn, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5), 604\u2013607. https:\/\/doi.org\/10.1161\/01.STR.19.5.604 (1988).","journal-title":"Stroke"},{"issue":"2","key":"46124_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"R Hughes","year":"2001","unstructured":"Hughes, R. et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 50(2), 195\u2013201. https:\/\/doi.org\/10.1002\/ana.1088 (2001).","journal-title":"Ann. Neurol."},{"key":"46124_CR17","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney, F. I. & Barthel, D. W. Functional evaluation: The barthel index: A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med. J. 14, 61\u201365 (1965).","journal-title":"Md State Med. J."},{"issue":"8","key":"46124_CR18","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall, J. C. et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20(8), e192\u2013e197. https:\/\/doi.org\/10.1016\/S1473-3099(20)30483-7 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"7872","key":"46124_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"304","author":"G Teasdale","year":"1974","unstructured":"Teasdale, G. & Jennett, B. Assessment of coma and impaired consciousness: A practical scale. The Lancet 304(7872), 81\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(74)91639-0 (1974).","journal-title":"The Lancet"},{"issue":"4","key":"46124_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53(4), 695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"46124_CR21","unstructured":"Smith A. Symbol Digit Modalities Test (SDMT). (Western Psychological Services, 1982)."},{"key":"46124_CR22","unstructured":"MacLullich A. The 4 'A's Test. Published October 30, 2014. Accessed July 7, 2022. www.the4at.com"},{"issue":"7","key":"46124_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/00003246-200107000-00012","volume":"29","author":"EW Ely","year":"2001","unstructured":"Ely, E. W. et al. Evaluation of delirium in critically ill patients: Validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit. Care Med. 29(7), 1370 (2001).","journal-title":"Crit. Care Med."},{"issue":"10","key":"46124_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00115-004-1729-0","volume":"75","author":"P Scherer","year":"2004","unstructured":"Scherer, P., Baum, K., Bauer, H., G\u00f6hler, H. & Miltenburger, C. Normierung der brief repeatable battery of neuropsychological tests (BRB-N) f\u00fcr den deutschsprachigen Raum Anwendung bei schubf\u00f6rmig remittierenden und sekund\u00e4r progredienten multiple-sklerose-patienten. Nervenarzt 75(10), 984\u2013990. https:\/\/doi.org\/10.1007\/s00115-004-1729-0 (2004).","journal-title":"Nervenarzt"},{"issue":"2","key":"46124_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-180080","volume":"64","author":"AE Thomann","year":"2018","unstructured":"Thomann, A. E. et al. The montreal cognitive assessment: Normative data from a German-speaking cohort and comparison with international normative samples. J. Alzheimers Dis. 64(2), 643\u2013655. https:\/\/doi.org\/10.3233\/JAD-180080 (2018).","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"46124_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S2213-2600(20)30559-2","volume":"9","author":"RK Gupta","year":"2021","unstructured":"Gupta, R. K. et al. Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: A prospective cohort study. The Lancet Respir. Med. 9(4), 349\u2013359. https:\/\/doi.org\/10.1016\/S2213-2600(20)30559-2 (2021).","journal-title":"The Lancet Respir. Med."},{"key":"46124_CR27","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Development and validation of the 4C mortality score. BMJ. 370, m3339. https:\/\/doi.org\/10.1136\/bmj.m3339 (2020).","journal-title":"BMJ."},{"key":"46124_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12644","author":"L Crivelli","year":"2022","unstructured":"Crivelli, L. et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12644 (2022).","journal-title":"Alzheimers Dement."},{"issue":"1","key":"46124_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12879-021-06185-6","volume":"21","author":"JI Guerrero","year":"2021","unstructured":"Guerrero, J. I. et al. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect. Dis. 21(1), 515. https:\/\/doi.org\/10.1186\/s12879-021-06185-6 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"46124_CR30","doi-asserted-by":"publisher","first-page":"e0283827","DOI":"10.1371\/journal.pone.0283827","volume":"18","author":"A-R Hanganu","year":"2023","unstructured":"Hanganu, A.-R. et al. Peripheral nervous system involvement associated with COVID-19. A systematic review of literature. PLoS One. 18(4), e0283827. https:\/\/doi.org\/10.1371\/journal.pone.0283827 (2023).","journal-title":"PLoS One."},{"key":"46124_CR31","doi-asserted-by":"publisher","first-page":"107263","DOI":"10.1016\/j.clineuro.2022.107263","volume":"217","author":"A Taskiran-Sag","year":"2022","unstructured":"Taskiran-Sag, A. et al. Headache and cognitive disturbance correlate with ganglion cell layer thickness in patients who recovered from COVID-19. Clin. Neurol. Neurosurg. 217, 107263. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107263 (2022).","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"7","key":"46124_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2009.75","volume":"5","author":"W Zink","year":"2009","unstructured":"Zink, W., Kollmar, R. & Schwab, S. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat. Rev. Neurol. 5(7), 372\u2013379. https:\/\/doi.org\/10.1038\/nrneurol.2009.75 (2009).","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"46124_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/CCM.0000000000000040","volume":"42","author":"E Fan","year":"2014","unstructured":"Fan, E. et al. Physical complications in acute lung injury survivors: A two-year longitudinal prospective study. Crit. Care Med. 42(4), 849\u2013859. https:\/\/doi.org\/10.1097\/CCM.0000000000000040 (2014).","journal-title":"Crit. Care Med."},{"issue":"4","key":"46124_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.ccm.0000157969.46388.a2","volume":"33","author":"S Bercker","year":"2005","unstructured":"Bercker, S. et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit. Care Med. 33(4), 711\u2013715. https:\/\/doi.org\/10.1097\/01.ccm.0000157969.46388.a2 (2005).","journal-title":"Crit. Care Med."},{"issue":"7","key":"46124_CR35","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.clinph.2021.03.016","volume":"132","author":"R Frithiof","year":"2021","unstructured":"Frithiof, R. et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin. Neurophysiol. 132(7), 1733\u20131740. https:\/\/doi.org\/10.1016\/j.clinph.2021.03.016 (2021).","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"46124_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet, M., Geddes, J. R., Husain, M., Luciano, S. & Harrison, P. J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry. 8(5), 416\u2013427. https:\/\/doi.org\/10.1016\/S2215-0366(21)00084-5 (2021).","journal-title":"The Lancet Psychiatry."},{"key":"46124_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jad.2021.09.098","volume":"296","author":"E Robinson","year":"2022","unstructured":"Robinson, E., Sutin, A. R., Daly, M. & Jones, A. A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020. J. Affect. Disord. 296, 567\u2013576 (2022).","journal-title":"J. Affect. Disord."},{"issue":"6","key":"46124_CR38","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1111\/ene.15307","volume":"29","author":"V Rass","year":"2022","unstructured":"Rass, V. et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur. J. Neurol. 29(6), 1685\u20131696. https:\/\/doi.org\/10.1111\/ene.15307 (2022).","journal-title":"Eur. J. Neurol."},{"key":"46124_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15324","author":"R Ferrucci","year":"2022","unstructured":"Ferrucci, R. et al. One-year cognitive follow-up of COVID-19 hospitalized patients. Eur. J. Neurol. https:\/\/doi.org\/10.1111\/ene.15324 (2022).","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"46124_CR40","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cid\/ciab611","volume":"74","author":"J See\u00dfle","year":"2022","unstructured":"See\u00dfle, J. et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin. Infect. Dis. 74(7), 1191\u20131198. https:\/\/doi.org\/10.1093\/cid\/ciab611 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"46124_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","volume":"146","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh, S. et al. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain 146(2), 421\u2013437. https:\/\/doi.org\/10.1093\/brain\/awac328 (2023).","journal-title":"Brain"},{"key":"46124_CR42","unstructured":"Larsson J. in Area-Proportional Euler and Venn Diagrams with Ellipses [R Package Eulerr Version 6.1.1] (2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46124-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:07:29Z","timestamp":1699625249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46124-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46124"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46124-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CBal, CBan, MB, TB, PC, SE, TF, SJG, CJH, EH, JI, CJ, TL, SGM, DKM, IS, KS, AKT, JT, LV, CV & GW have nothing to disclose. BEOJ reports research grants from Gilead, GSK, and Roche, travel support from Gilead, honoraria for lectures\/presentations from Gilead, GSK, and Fresenius Medical Care, served on advisory boards for Gilead, and is an (unpaid) member of the COVRIIN expert group at the Robert-Koch-Institute. IKP reports research support from the German MS Society, Celgene, Novartis, Roche, and Teva, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Almirall, Biogen, BMS, Celgene, Genzyme, Janssen, Merck, Novartis, Roche, and Teva, and served on advisory boards for Biogen, BMS, Celgene, Janssen, Medscape, and Novartis. AS reports research grants from the German Research Foundation, consulting fees from Abbott and Medtronic Inc., and speaker honoraria from Abbott, Boston Scientific, Medtronic Inc., and Novartis. PA reports research grants, speaker honoraria and travel support from Allergan, Abbvie, Biogen, Janssen Cilag, Bristol Myers Squibb, Celgene, Sanofi\/Genzyme, Ipsen, Merck, Merz, Novartis, Roche, Sanofi, and speaker honoraria from Lilly, Sandoz, Teva.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19619"}}